Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali
Condition: Malaria,Falciparum Interventions: Biological: Pfs230D1-EPA/Matrix-M Vaccine; Biological: Verorab Rabies Vaccine Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Novavax; Malaria Research and Training Center, Bamako, Mali Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Malaria | Malaria Vaccine | Mali Health | Research | Study | Training | Universities & Medical Training | Vaccines